(Q48481677)

11 February 2018

title

5HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding. (English)

1 reference

11 February 2018

1 reference

D L Li

1

1 reference

11 February 2018

R M Simmons

series ordinal

2

1 reference

11 February 2018

S Iyengar

series ordinal

3

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

11 February 2018

published in

Brain Research

1 reference

11 February 2018

volume

781

1 reference

11 February 2018

issue

1-2

1 reference

11 February 2018

page(s)

121-128

1 reference

11 February 2018

Pharmacotherapy of the eating disorders: a commentary

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

A new device for the rapid measurement of impaired motor function in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Chlordiazepoxide-fluoxetine interactions on food intake in free-feeding rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Stimulation of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of corticotropin releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Selective effects of CGS 10686B, dl-fenfluramine or fluoxetine on nutrient selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Food intake and selection pattern of rats treated with dexfenfluramine, fluoxetine and RU 24969.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Fluoxetine in the treatment of obese type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901221-3

10.1016/S0006-8993(97)01221-3

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9507085

1 reference

11 February 2018